Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07009743 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

O-RADS MRI System on Early Detection of Ovarian Cancer

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is designed to prospectively enroll individuals with suspected or potential risk of ovarian cancer across multiple centers. The investigation will implement rational optimization of the recommended imaging sequences and interpretation protocols within the standard Ovarian-Adnexal Reporting and Data System (O-RADS) MRI framework. By integrating comprehensive clinical parameters and histopathological correlations, we aim to validate the diagnostic efficacy and reproducibility of the optimized protocol against the standard O-RADS MRI system. The ultimate objective is to establish a refined methodology for accurately diagnosing early-stage or low-burden ovarian malignancies, thereby improving prognostic outcomes of patients with ovarian cancer.
Trial Details
NCT Number NCT07009743
Lead Sponsor Shanghai Gynecologic Oncology Group
Conditions
(from sponsor)		 Ovarian Cancer (OvCa), Ovarian Cancer Metastatic
Related terms Ovarian Neoplasms
Enrollment 2,549 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov